Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 315

Similar articles for PubMed (Select 9695037)

1.

Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment.

Byne W, White L, Parella M, Adams R, Harvey PD, Davis KL.

Int J Geriatr Psychiatry. 1998 Jul;13(7):473-9.

PMID:
9695037
2.

Prevalence and correlates of parkinsonism in an institutionalized population of geriatric patients with chronic schizophrenia.

Byne W, Stamu C, White L, Parrella M, Harvey PD, Davis KL.

Int J Geriatr Psychiatry. 2000 Jan;15(1):7-13.

PMID:
10637399
3.

Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics.

Altamura AC, Cavallaro R, Regazzetti MG.

Eur Arch Psychiatry Clin Neurosci. 1990;240(1):9-12.

PMID:
1979540
4.

The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.

Go CL, Rosales RL, Caraos RJ, Fernandez HH.

Parkinsonism Relat Disord. 2009 Nov;15(9):655-9. doi: 10.1016/j.parkreldis.2009.02.015. Epub 2009 Apr 5.

PMID:
19346155
5.

Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.

Miller DD, McEvoy JP, Davis SM, Caroff SN, Saltz BL, Chakos MH, Swartz MS, Keefe RS, Rosenheck RA, Stroup TS, Lieberman JA.

Schizophr Res. 2005 Dec 1;80(1):33-43. Epub 2005 Sep 19.

PMID:
16171976
6.
7.

Tardive dyskinesia and type II schizophrenia.

Davis EJ, Borde M, Sharma LN.

Br J Psychiatry. 1992 Feb;160:253-6.

PMID:
1347240
8.

A survey of tardive dyskinesia in psychiatric inpatients in Japan.

Koshino Y, Madokoro S, Ito T, Horie T, Mukai M, Isaki K.

Clin Neuropharmacol. 1992 Feb;15(1):34-43.

PMID:
1349507
9.

The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.

de Jesus Mari J, Lima MS, Costa AN, Alexandrino N, Rodrigues-Filho S, de Oliveira IR, Tollefson GD.

Eur Arch Psychiatry Clin Neurosci. 2004 Dec;254(6):356-61. Epub 2004 Nov 12.

PMID:
15538607
10.

Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.

Wu JQ, Chen da C, Xiu MH, Tan YL, Yang FD, Kosten TR, Zhang XY.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:71-7. doi: 10.1016/j.pnpbp.2013.06.013. Epub 2013 Jul 1.

PMID:
23827756
11.

Tardive dyskinesia in schizophrenics under 60 years of age.

Kolakowska T, Williams AO, Ardern M, Reveley MA.

Biol Psychiatry. 1986 Feb;21(2):161-9.

PMID:
2868762
12.

Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.

Li CR, Chung YC, Park TW, Yang JC, Kim KW, Lee KH, Hwang IK.

World J Biol Psychiatry. 2009;10(4 Pt 3):919-24. doi: 10.1080/15622970802481895.

PMID:
19995222
13.

Cognitive sequelae of tardive dyskinesia.

DeWolfe AS, Ryan JJ, Wolf ME.

J Nerv Ment Dis. 1988 May;176(5):270-4.

PMID:
2896762
14.
15.

Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.

Davidson M, Harvey PD, Powchik P, Parrella M, White L, Knobler HY, Losonczy MF, Keefe RS, Katz S, Frecska E.

Am J Psychiatry. 1995 Feb;152(2):197-207.

PMID:
7840352
16.

Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia.

Zhang XY, Chen da C, Qi LY, Wang F, Xiu MH, Chen S, Wu GY, Kosten TA, Kosten TR.

Psychopharmacology (Berl). 2009 Sep;205(4):647-54. doi: 10.1007/s00213-009-1590-8. Epub 2009 Jun 16.

PMID:
19529921
17.

Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia?

Waddington JL, O'Callaghan E, Larkin C, Kinsella A.

Brain Cogn. 1993 Sep;23(1):56-70.

PMID:
8105822
18.
19.

Tardive dyskinesia in the aged. Duration of treatment relationships.

Toenniessen LM, Casey DE, McFarland BH.

Arch Gen Psychiatry. 1985 Mar;42(3):278-84.

PMID:
2858189
20.

Tardive dyskinesia among Chinese and Malay patients with schizophrenia.

Chong SA, Mahendran R, Machin D, Chua HC, Parker G, Kane J.

J Clin Psychopharmacol. 2002 Feb;22(1):26-30.

PMID:
11799339
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk